Other languages Forte Biosciences, Inc.

Equities

FBRX

US34962G1094

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-03 pm EDT			5-day change	1st Jan Change
0.7141 ^USD	+3.46%		-0.31%	-13.09%

Mar. 18	Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 05	Camac Partners Provides Information to Shareholders	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Forte Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 18
Camac Partners Provides Information to Shareholders	Jan. 05
Forte Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13
Tocagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13
Forte Biosciences Filed a Motion to Dismiss the Amended Complaint	23-10-28
Camac Fund Files an Amended Class Action and Derivative Complaint	23-10-20
Forte Biosciences, Inc. Announces Directorate Appointments	23-09-20
Camac Partners Shares Key Facts that Reinforce the Need for Urgent Change in Forte Biosciences?s Boardroom	23-09-06
Forte Biosciences Issues an Investor Presentation to Shareholders	23-09-01
Forte Biosciences, Inc Receives Shareholder Proposal from Funicular Funds, LP	23-08-24
Forte Biosciences, Inc Receives Shareholder Proposal from ATG Capital Management LLC	23-08-24
Camac Partners, LLC Files a Definitive Proxy Statement with Securities and Exchange Commission	23-08-24
Camac Partners, LLC Files a Revised Preliminary Proxy Statement with Securities and Exchange Commission	23-08-17
Forte Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14
Funicular Funds Submits a Shareholder Proposal to Forte Biosciences	23-08-02
ATG Capital Management Submits a Shareholder Proposal to Forte Biosciences	23-08-02
Cable Car Capital Submits a Shareholder Proposal to Forte Biosciences	23-07-06
Camac Partners Solicits Proxies from Shareholders of Forte Biosciences	23-05-25
Forte Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15
Tocagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Forte Biosciences, Inc.

Equities

FBRX

US34962G1094

Other languages

Filters